生研生物:预计截至2026年3月31日年度净亏损约109万美元

美股速递
Aug 01

生研生物(Cellyan Biotechnology Co Ltd)发布业绩预告。公司预计,在截至2026年3月31日的财年内,将录得净亏损,数额约为109万美元。这一前瞻性数据,揭示了企业在过去一个财年中的财务表现与挑战。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10